Senior Technology Development Strategist
Dr. Tyvoll brings to AMI-USC a critical focus on intellectual property. He applies an intensive effort to build AMI’s patent portfolios in a strategic and vigilant way.
David has more than 20 years of industrial experience at companies like Hewlett Packard and Silverbrook Research, as well as at other private intellectual property licensors and aggregators. He is an inventor on 48 US patents. Working with USC researchers, he founded Okami Therapeutics to develop treatments for autoimmune diseases such as lupus and certain leukemias.
David has a Bachelor of Science degree in Chemistry from Revelle College at the University of California, San Diego, a PhD in chemistry from Stanford University, a post-doctoral position in physics at Stanford University, and a Master of Business Administration degree from the University of California, Los Angeles.
Dr. Tyvoll may be contacted at tyvoll AT usc DOT edu.